Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05386173 · ClinicalTrials.gov registry record
Effect of Fetal Aortic Valvuloplasty on Outcomes
A clinical trial of Congenital Heart Disease and Aortic Valve Stenosis, sponsored by Queen Silvia Children's Hospital, Gothenburg, Sweden.
- Recruiting
- Registry status
- 200
- Enrollment target
- 13
- Study locations
NCT05386173 is a study of Congenital Heart Disease and Aortic Valve Stenosis that is actively recruiting participants, run by Queen Silvia Children's Hospital, Gothenburg, Sweden. The registered enrollment target is 200 participants, below the 471-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (58% lower). The trial reports 13 study locations across 3 states.
The verdict
NCT05386173, a study of Congenital Heart Disease and Aortic Valve Stenosis, is actively recruiting participants, sponsored by Queen Silvia Children's Hospital, Gothenburg, Sweden.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 13
- Study locations
Study Summary
In one of the most severe congenital heart defects, hypoplastic left heart syndrome (HLHS), the left ventricle is underdeveloped and the prognosis is worse than in most other heart defects. The underdevelopment can occur gradually during fetal growth caused by a narrowing of the aortic valve. At some international centers, such fetuses are treated with a balloon dilation of the narrowed valve, but there is no scientifically sound evidence that this treatment is effective. The aim of this study is: 1/ to evaluate whether balloon dilation during the fetal period of a narrowed aortic valve can reduce the risk of the left ventricle becoming underdeveloped and the baby being born with a so-called univentricular heart (HLHS); 2/ to investigate whether such treatment improves the prognosis for this group of children with a very complex and severe heart defect and 3/ to also describe side effects and risks in fetuses and mothers of the fetal procedure.
Conditions Studied
Interventions
- PROCEDURE Fetal aortic balloon dilatation
Study Locations (13)
Other
- Kinderherzzentrum Linz - Linz
- The Hospital for Sick Children Toronto - Toronto
- Department of Paediatric Cardiology, Helsinki University Children's Hospital - Helsinki
- Pediatric Cardiology - University Hospital Bonn - Bonn
- Department of Pediatric and Congenital Cardiology, University of Heidelberg - Heidelberg
- University hospital Technical university, mother- and-child center - Munich
- Department of Perinatal Cardiology and Congenital Anomalies, Centre of Postgraduate Medical Education. - Warsaw
- Fetal Medicine Unit, Dept. Obstetrics & Gynecology University Hospital 12 de Octubre - Madrid
- Department of Pediatric Cardiology, Skane University Hospital - Lund
- Department of pediatric cardiology, Karolinska Institute - Stockholm
- Department of Pediatrics, Umeå University Hospital - Umeå
California
- Fetal Cardiovascular Program, University of California San Francisco - San Francisco
Ohio
- Congenital Heart Collaborative, Nationwide Children's Hospital - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2029-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05386173
The ClinicalTrials.gov registry entry for NCT05386173 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 471-participant average among 63 other Congenital Heart Disease trials with a reported enrollment target (58% lower). The listed sponsor is Queen Silvia Children's Hospital, Gothenburg, Sweden, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Congenital Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which Fetal aortic balloon dilatation is the first listed.
NCT05386173 reports 13 study locations spanning 3 distinct geographic areas - top geographies include Other, California, Ohio.
Frequently Asked Questions
What is clinical trial NCT05386173 about?
NCT05386173 is a clinical study titled "Effect of Fetal Aortic Valvuloplasty on Outcomes". In one of the most severe congenital heart defects, hypoplastic left heart syndrome (HLHS), the left ventricle is underdeveloped and the prognosis is worse than in most other heart defects. The underdevelopment can occur gradually during fetal growth caused by a narrowing of the aortic valve. At som...
What is the current status of trial NCT05386173?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2021-01-01. Estimated completion is 2029-12-31.
What conditions does trial NCT05386173 study?
This clinical trial studies the following conditions: Congenital Heart Disease, Aortic Valve Stenosis, Hypoplastic Left Heart Syndrome, Fetal Cardiac Disorder.
What interventions are being tested in trial NCT05386173?
The interventions under investigation include: Fetal aortic balloon dilatation (PROCEDURE).
Who is sponsoring clinical trial NCT05386173?
This trial is sponsored by Queen Silvia Children's Hospital, Gothenburg, Sweden, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05386173 being conducted?
This trial has 13 study locations across California, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Congenital Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Fontan Fitness Trial
RECRUITING · NA
-
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
RECRUITING
-
A Study of Invasive Hemodynamic for MACHD Registry
RECRUITING
-
Remote Monitoring in Pregnant Women With Congenital Heart Disease Using Wrist Wearables
RECRUITING
-
Fetal Electrophysiologic Abnormalities in High-Risk Pregnancies Associated With Fetal Demise
RECRUITING
-
PDA for Kidneys Study
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.